VR Logo

Wanbury Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1988

Chairman: --

Managing Director: --

Group: --

Listing: NSE: WANBURY, BSE: 524212

Headquarters: Navi Mumbai, Maharashtra

Website: www.wanbury.com

Key Facts

Market cap: R 49.24 Cr

Revenue (TTM): R 401.97 Cr

Earnings (TTM): R -7.81 Cr

Cash: R 5.25 Cr

Total Debt: R 232.99 Cr

Promoters' ownership: 54.93%

Liquidity: Moderate

52 Week range: R 10.75 - 33.40

Face value: R10.00

Shares outstanding: 2,49,95,117

10 Years Aggregate:

  • CFO: 532.50 Cr
  • EBITDA: -22.47 Cr
  • Net Profit: -327.99 Cr

Stock Performance

Time Period Wanbury S&P BSE Healthcare S&P BSE Small Cap
YTD9.8717.93-15.54
1 month-7.833.294.22
3 months-22.8513.75-15.99
1 Year2.2317.97-22.54
3 Years-23.704.50-8.90
5 Years-17.48-0.111.33
10 Years-12.4811.122.98
As on 03-Jun-2020
Year Wanbury S&P BSE Small Cap S&P BSE Healthcare
2019-9.27-6.85-3.55
2018-53.97-23.41-5.89
2017-27.9259.640.49
2016-29.881.77-12.88
2015214.906.7615.06
20149.7969.2447.43
201310.33-11.2322.55

Review & Analysis